Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2024-11-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
关于参加2024年度深圳辖区上市公司集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (543 characters) about the company's participation in a 2024 investor interaction event organized by regulatory and stock exchange authorities. It mentions the date and format of the event and invites investors to participate. There is no financial data, no detailed report, no voting results, no management changes, or other specific filings. The document is an announcement related to investor communication but does not contain a report or transcript itself. Given the short length and nature, it is best classified as a Regulatory Filing (RNS) as a general announcement that does not fit other categories.
2024-11-29 Chinese
监事会关于第九届监事会第十六次会议相关事项的意见
Regulatory Filings Classification · 95% confidence The document is a supervisory board opinion on a rectification report related to regulatory corrective measures imposed by the Shenzhen Securities Regulatory Bureau. It discusses compliance and corrective actions but does not contain financial statements or detailed audit results. The document is short (390 characters) and appears to be a formal opinion or statement rather than a full audit or annual report. It relates to regulatory compliance and corrective measures, fitting best under Regulatory Filings (RNS) as it does not meet criteria for Audit Report (AR) or other specific categories.
2024-11-29 Chinese
关于中国证券监督管理委员会深圳监管局对公司采取责令改正措施决定的整改报告
Audit Report / Information Classification · 95% confidence The document is a detailed corrective action report issued by Shenzhen Haier Bioengineering Co., Ltd. in response to a regulatory decision by the Shenzhen Securities Regulatory Commission. It outlines the company's self-examination, identified issues related to information disclosure and financial accounting irregularities, and the corrective measures taken. The document includes references to regulatory rules, internal governance improvements, and ongoing compliance efforts. It is not a financial report like an annual or interim report, nor is it a simple announcement or certification. Instead, it is a comprehensive report on audit findings and corrective actions related to regulatory compliance and accounting practices, fitting the definition of an Audit Report / Information (AR). The document length (7107 characters) and content depth support this classification rather than a brief announcement or regulatory filing. FY 2024
2024-11-29 Chinese
第九届董事局第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board of directors meeting resolution by Shenzhen Haiwang Bioengineering Co., Ltd. It details the convening of the 19th meeting of the 9th board, the review and approval of a rectification report in response to regulatory corrective measures issued by the Shenzhen Securities Regulatory Bureau. The document includes voting results and references to related announcements but does not contain financial statements or detailed financial data. It is primarily about board decisions and regulatory compliance actions, not a full audit report or annual report. Therefore, it fits best under Board/Management Information (MANG). The document length is short (1104 characters), and it is not a report publication announcement or certification letter, so those categories are excluded.
2024-11-29 Chinese
第九届监事会第十六会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a resolution passed at the 16th meeting of the 9th Supervisory Board of Shenzhen Haiwang Bioengineering Co., Ltd. It details the meeting's convening, the agenda item regarding a rectification report related to a regulatory corrective action by the Shenzhen Securities Regulatory Bureau, and the voting results. The document does not contain financial statements or detailed financial data, nor is it a report itself. It is a regulatory announcement about a board meeting decision and related compliance matters. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-11-29 Chinese
关于完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Haiwang Bioengineering Co., Ltd. regarding the completion of industrial and commercial registration changes related to a reduction in registered capital and amendments to the company articles of association. It includes details of the capital change and official registration information. The document is short (1043 characters) and serves as a formal notice of a corporate action rather than a financial report or detailed filing. It does not contain financial statements or detailed analysis. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about corporate registration changes.
2024-11-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.